Department of Epidemiology and Biostatistics, School of Public Health, Zhejiang University, Hangzhou, China.
Department of Chronic Disease and Health Promotion, Yinzhou District Center for Disease Control and Prevention, Ningbo, China.
Nutr Metab Cardiovasc Dis. 2019 Nov;29(11):1205-1213. doi: 10.1016/j.numecd.2019.07.007. Epub 2019 Jul 12.
The relationship between serum total cholesterol (TC) and mortality remains inconsistent. Additionally, intra-individual variability of cholesterol has been of increasing interest as a new indicator for health outcomes. We aimed to examine the association between TC and its variability and risk of mortality.
We performed a retrospective cohort study with 122,645 individuals aged over 40 years in Ningbo, China. The intra-individual variability was calculated using four metrics including standard deviation, coefficient variation, variation independent of mean and average successive variability. Hazard ratios and 95% confidence intervals were estimated for the associations of baseline and variability in TC with risk of mortality by Cox proportional hazards regression models. During 591,585.3 person-years of follow-up, 4563 deaths (including 1365 from cardiovascular disease, 788 from stroke and 1514 from cancer) occurred. A U-shaped association was observed for baseline TC level and risk of total, cardiovascular and cancer mortality, with lowest mortality at 5.46 mmol/L, 5.04 mmol/L and 5.51 mmol/L, respectively. As compared with subjects with TC variability in the lowest quartile, individuals in the highest quartile had 21% higher risk of all-cause mortality (HR = 1.21, 95% CI: 1.05 to 1.40), and 41% higher risk of CVD mortality (HR = 1.41, 95%CI: 1.10 to 1.81).
Both too low and too high baseline TC level were associated with higher risk of total, cardiovascular disease and cancer mortality. Variability of TC could be a risk factor of total and CVD mortality, independent of mean TC level. Future studies are needed to confirm these findings.
血清总胆固醇(TC)与死亡率之间的关系仍不一致。此外,胆固醇的个体内变异性作为健康结果的新指标越来越受到关注。我们旨在研究 TC 及其变异性与死亡率风险之间的关系。
我们在中国宁波进行了一项回顾性队列研究,纳入了 122645 名年龄在 40 岁以上的个体。使用标准差、变异系数、均值独立变异和平均连续变异四个指标来计算个体内变异性。通过 Cox 比例风险回归模型估计 TC 基线和变异性与死亡率风险之间的关联。在 591585.3 人年的随访期间,发生了 4563 例死亡(包括 1365 例心血管疾病、788 例卒中和 1514 例癌症)。TC 基线水平与全因、心血管疾病和癌症死亡率之间存在 U 形关联,死亡率最低的水平分别为 5.46mmol/L、5.04mmol/L 和 5.51mmol/L。与 TC 变异性最低四分位的个体相比,四分位最高的个体全因死亡率的风险增加了 21%(HR=1.21,95%CI:1.05 至 1.40),心血管疾病死亡率的风险增加了 41%(HR=1.41,95%CI:1.10 至 1.81)。
TC 基线水平过低和过高都与全因、心血管疾病和癌症死亡率风险增加相关。TC 的变异性可能是全因和 CVD 死亡率的一个风险因素,独立于 TC 平均水平。需要进一步的研究来证实这些发现。